ADMA
ADMA Biologics Inc
9.40$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.9% | +10.8% | +30.9% | +11.8% | -1.9% | -2.3% | +6.3% | +10.0% | +3.7% | -17.7% | +8.6% | – | |
| – | +0.5% | -0.1% | +16.3% | +21.0% | -9.9% | -0.9% | +2.0% | +7.0% | -14.1% | -33.0% | +13.0% | – | |
| – | +26.1% | +25.8% | +46.9% | +3.8% | +6.2% | -3.5% | +10.0% | +12.5% | +17.4% | -9.1% | +6.8% | – | |
| – | -25.3% | +1.0% | +24.4% | -26.4% | -5.1% | +111.3% | +24.8% | +48.2% | -9.9% | +88.7% | +131.6% | – | |
| – | +5.5% | +0.7% | +6.2% | +11.8% | +25.6% | +3.3% | -7.7% | -2.0% | +8.0% | +13.7% | 0.0% | – | |
| – | +5.5% | +2.6% | +5.6% | +9.7% | +24.9% | +4.8% | -6.8% | +0.8% | +5.9% | +16.6% | +11.3% | – | |
| – | +63.9% | +53.3% | +79.6% | +1.1% | -3.3% | -9.0% | +22.7% | +19.2% | +23.0% | -19.9% | +4.3% | – | |
| – | -2.9% | -39.4% | +0.4% | -7.5% | -17.7% | -31.4% | -7.1% | -8.7% | -2.9% | +29.2% | +63.0% | – | |
| – | -787.9% | – | +94.8% | +2.5% | -5.5% | -3.6% | +19.9% | +18.5% | +29.6% | -7.3% | -12.1% | – | |
| – | -100.0% | – | +536.8% | -77.8% | -9,288.5% | – | -10.2% | +88.6% | +10.2% | -3.4% | +5.2% | – | |
| – | -787.9% | – | +80.1% | +12.0% | +211.6% | -76.0% | +27.2% | +6.5% | +35.6% | -8.2% | -16.6% | – | |
| – | -184.3% | – | +71.6% | +1.2% | -6.3% | -5.4% | +17.6% | +16.4% | +27.4% | -6.4% | -6.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.